Effect of a blood-saving technique on transfusions after heart surgery
Part of Heart & circulation clinical trials.
This trial tests whether a technique called retrograde autologous priming (using the patient's own blood to prepare the heart-lung machine) can reduce the need for blood transfusions during heart surgery. It is looking at hospitals and surgical teams, not individual patients, so it's not a typical trial you can join directly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your surgery must be done at a hospital that performs more than 200 adult heart surgeries a year.
- Your heart surgery team must agree to use both methods of priming the heart-lung machine as part of the trial.
- Your surgery must use a heart-lung machine (cardiopulmonary bypass).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
This trial tests whether collecting and re-infusing your own blood during heart surgery reduces the need for donor blood transfusions. It's for adults having planned bypass surgery with a heart-lung machine.
This trial looks at how a device that collects and reuses your own blood during heart surgery works. It may help reduce the need for donated blood.
This study tests whether giving blood transfusions based on each patient's needs during and after heart surgery is safe and effective. It compares different transfusion thresholds to see which works better.
This trial studies giving a “fresh” blood transfusion from your own blood after heart surgery that uses a heart-lung machine. It may help patients avoid needing donated blood, but it only works for people who meet specific safety and timing requirements.
This study tests a new way to manage blood during surgery, which may reduce the need for donor blood transfusions. It compares standard care with a method that uses your own blood and a special device to monitor your blood flow.
Hear when a new Red Blood Cell Transfusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.